Thursday, February 19, 2026 2/19/2026

The role of protein O-linked N-Acetylglucosamine in regulating cardiac physiology

Award Number: R21HL152354
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/09/2020
PERIOD OF PERFORMANCE END DATE: 08/31/2024

Group Awards By:

View Award Description

The role of protein O-linked N-Acetylglucosamine in regulating cardiac physiology - The post-translational modification of serine and threonine residues on proteins by O-linked N-acetylglucosamine (O-GlcNAc), is increasingly recognized as being as abundant as phosphorylation and playing a similarly important role in regulating diverse cell functions including cell cycle, transcription, protein degradation, mitochondrial function, autophagy, circadian rhythm, and cell survival. Activation of the hexosamine biosynthesis pathway, which regulates protein O-GlcNAcylation has been associated with increased lifespan in both C. elegans and mice. In the heart dysregulation in O-GlcNAc homeostasis has been linked to different disease processes including cardiac hypertrophy, heart failure, the adverse effects of diabetes and age-related changes in cardiomyocytes. On the other hand, acute increases in O-GlcNAc levels promotes resilience of cardiomyocytes in response to ischemia/reperfusion injury. We have shown that O-GlcNAcylation regulates physiological processes that are key to maintaining healthy cardiomyocytes. Our preliminary data also show that fasting increases O-GlcNAc levels in the heart, strongly supporting a physiological role for protein O- GlcNAcylation. Despite the association of O-GlcNAc with cardiac disease our knowledge of the basic regulatory mechanisms in the normal healthy heart remains limited, there is growing evidence that O-GlcNAc cycling contributes to the regulation of normal physiological processes in a healthy heart. A lack of understanding of the fundamental biology underlying how O-GlcNAc regulates normal cardiomyocyte function represents a major gap in our knowledge and limits the potential for modulation of O-GlcNAc homeostasis in the treatment of cardiac disease. Consequently, we believe that there is an urgent need to better understand the basic biology underlying the effects of O-GlcNAc on cardiomyocyte function. Therefore, we will test the hypothesis that protein O- GlcNAcylation plays an integral role in normal cardiomyocyte homeostasis contributing to cardiomyocyte resilience in response to physiological stimuli. We will test this hypothesis with two specific aims: 1) Determine how changes in O-GlcNAc levels influence the molecular and cellular responses of the heart to fasting; and 2) Determine how physiological stimuli influence the temporal and intracellular localization of OGT and OGA, and O-GlcNAc. We will use inducible cardiomyocyte specific mouse models to increase or decrease O-GlcNAc levels in the heart, genetically based O-GlcNAc FRET sensors, and fluorescently tagged OGT and OGA to determine the spatiotemporal dynamics of O-GlcNAc that occur in response to physiological stimuli. The successful completion of the proposed studies will yield significant new information on the role of O-GlcNAc in regulating normal cardiac physiology including its role in maintaining cardiomyocyte resilience. This application is directly responsive to PA-19-049 by focusing on improving our fundamental knowledge of the cardiac glycome and its ability to regulate cardiovascular biology. These findings will lay the foundation that will help further our understanding of this signaling pathway in cardiac health and resilience.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = -$300 )
2025	2021	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH STREET	BIRMINGHAM	AL	35294	JEFFERSON	USA	Cardiovascular Diseases Research	000	2	12/29/2024	NON-COMPETING CONTINUATION	-$300
														Subtotal = -$300

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2021	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Cardiovascular Diseases Research	000	2	8/14/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2021 ( Subtotal = $185,625 )
2021	2021	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Cardiovascular Diseases Research	000	2	7/30/2021	NON-COMPETING CONTINUATION	$185,625
														Subtotal = $185,625

Issue Date FY: 2020 ( Subtotal = $222,750 )
2020	2020	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Cardiovascular Diseases Research	000	1	7/9/2020	NEW	$222,750
														Subtotal = $222,750

Grand Total All Awards = $408,075

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The role of protein O-linked N-Acetylglucosamine in regulating cardiac physiology

Award Number: R21HL152354

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/09/2020

PERIOD OF PERFORMANCE END DATE: 08/31/2024

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer